Using SORE6, we previously detected/purified a small subset of SORE6+ cells in two FLT3-mutated AML cell lines and found that SORE6+ cells have significantly higher CSL phenotype than the bulk SORE6− cells, including chemoresistance [13]. This evidence concerns the gene FLT3 and acute myeloid leukemia.